These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16170769)

  • 1. Modeling the potential public health impact of imperfect HIV vaccines.
    Blower S
    J Infect Dis; 2005 Oct; 192(8):1494-5; author reply 1495-6. PubMed ID: 16170769
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential public health impact of imperfect HIV type 1 vaccines.
    Anderson R; Hanson M
    J Infect Dis; 2005 Feb; 191 Suppl 1():S85-96. PubMed ID: 15627235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical assessment of public health impact of imperfect prophylactic HIV-1 vaccines with therapeutic benefits.
    Elbasha EH; Gumel AB
    Bull Math Biol; 2006 Apr; 68(3):577-614. PubMed ID: 16794946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the population level effects of an HIV-1 vaccine in an era of highly active antiretroviral therapy.
    Rida W; Sandberg S
    Bull Math Biol; 2009 Apr; 71(3):648-80. PubMed ID: 19214640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic insights into the population level impact of imperfect prophylactic HIV vaccines.
    Abu-Raddad LJ; Boily MC; Self S; Longini IM
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):454-67. PubMed ID: 17554215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of incidence function in vaccine-induced backward bifurcation in some HIV models.
    Sharomi O; Podder CN; Gumel AB; Elbasha EH; Watmough J
    Math Biosci; 2007 Dec; 210(2):436-63. PubMed ID: 17707441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV models to inform health policy.
    Stover J
    Curr Opin HIV AIDS; 2011 Mar; 6(2):108-13. PubMed ID: 21505384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV vaccines under study.
    Ravanfar P; Mendoza N; Satyaprakash A; Jordan BI
    Dermatol Ther; 2009; 22(2):158-67. PubMed ID: 19335727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be?
    Smith RJ; Schwartz EJ
    Math Biosci; 2008 Apr; 212(2):180-7. PubMed ID: 18359048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
    Robinson HL; Weinhold KJ
    J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of imperfect vaccines on the evolution of HIV virulence.
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Med Hypotheses; 2006; 66(5):907-11. PubMed ID: 16442745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS vaccine test to be expanded based on upbeat results.
    AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytokines as adjuvants for improving anti-HIV responses.
    Morrow MP; Weiner DB
    AIDS; 2008 Jan; 22(3):333-8. PubMed ID: 18195559
    [No Abstract]   [Full Text] [Related]  

  • 15. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 16. Outwitting HIV: Minnesota researchers take on a clever virus.
    Bell H
    Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine research going back to square one.
    AIDS Read; 2008 Apr; 18(4):166, 208. PubMed ID: 18472426
    [No Abstract]   [Full Text] [Related]  

  • 19. The prime-boost concept applied to HIV preventive vaccines.
    Excler JL; Plotkin S
    AIDS; 1997; 11 Suppl A():S127-37. PubMed ID: 9451976
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral AIDS vaccine used in Thailand.
    AIDS Patient Care STDS; 2007 Nov; 21(11):894. PubMed ID: 18338436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.